Welcome to our dedicated page for Brightspring Health Services SEC filings (Ticker: BTSGU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Brightspring Health Services's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Brightspring Health Services's regulatory disclosures and financial reporting.
BrightSpring Health Services President, Community Living, Robert Allen Barnes reported a routine tax-related share disposition. On March 30, 2026, 6,748 shares of common stock were withheld by the company to cover taxes due on the vesting of 15,540 restricted stock units at a net settlement price of $41.54 per share. Following this withholding, Barnes directly holds 25,549 shares of BrightSpring Health Services common stock. This was not an open-market purchase or sale but an administrative step tied to equity compensation.
BrightSpring Health Services completed the previously announced sale of its Community Living business, including community living services, waiver programs, and intermediate care facilities, to Sevita for aggregate cash consideration of $835 million, subject to customary working capital and other adjustments. A BrightSpring subsidiary, Res-Care, transferred the related assets, equity interests, and liabilities under a purchase agreement signed in January 2025 and amended in December 2025.
BrightSpring’s unaudited pro forma statements show the sale as if it occurred on December 31, 2025, and include an expected $425 million repayment of first lien term loan debt. The estimated after-tax gain on the sale is $31.978 million, with a modest reduction in annual interest expense. Following closing, Robert Barnes, President of ResCare Community Living, resigned and received accelerated vesting of 15,540 restricted stock units and 5,640 stock options; his departure was not due to any disagreement with the company.
The Vanguard Group amended a Schedule 13G/A reporting its beneficial ownership in BrightSpring Health Services Inc. The filing states amount beneficially owned: 0 shares and percent of class: 0%. It explains an internal realignment on January 12, 2026 that caused certain Vanguard subsidiaries or business divisions to report holdings separately in reliance on SEC Release No. 34-39538. The filing is signed by Ashley Grim on 03/26/2026.
BrightSpring Health Services director and officer Jon B. Rousseau reported multiple bona fide gifts of fully vested stock options on Common Stock. The filing shows six gift transfers covering 1,132,322 options with a conversion price of $22.29 per share, mainly to the Rousseau Family Trust, the reporting person’s spouse and The Margaret Rousseau Children Trust. These are non-cash, off-market gifts, not open-market sales or purchases. The filing notes that Rousseau disclaims beneficial ownership of indirectly held securities except to the extent of his pecuniary interest.
BrightSpring Health Services, Inc. executive Scott A. Greenwell, President of PharMerica, reported equity compensation awards on common stock and stock options. He acquired stock options for 49,073 shares at an exercise price of $0.00 per share and 20,020 shares of common stock as a grant.
According to the footnotes, the 20,020-share common stock award consists of restricted stock units that vest in three equal annual installments beginning on January 25, 2027. The 49,073 stock options also vest in three equal annual installments starting on that same date, aligning his compensation with long-term company performance.
BrightSpring Health Services officer Lisa A. Nalley reported several equity transactions. On March 4, 2026, she exercised stock options for 30,000 shares of common stock at $6.37 per share and sold 30,000 shares in a registered public offering at $41.15 per share.
That day also reflected vesting of previously granted performance-based stock options from 2019 and 2020, which became fully vested after performance conditions were satisfied. On March 5, 2026, she received 21,354 restricted stock units and 52,344 stock options, generally vesting in three equal annual installments beginning January 25, 2027.
BrightSpring Health Services director and officer Jon B. Rousseau reported a mix of equity grants, option activity, and share sales. On March 4, 2026, he exercised 220,000 stock options at $6.37 per share and sold 220,000 common shares at $41.15 per share in a registered public offering.
On March 4–5, 2026, he was awarded several blocks of stock options and restricted stock units (RSUs), including 458,008 options, 955,823 options, and 186,845 RSUs. Some options are fully vested, while others and the RSUs vest in twelve equal quarterly installments starting April 25, 2026. After these transactions, he directly owned about 1,023,880 common shares, plus additional option and share interests held indirectly through family trusts, for which he disclaims beneficial ownership beyond his economic interest.
BrightSpring Health Services Chief Financial Officer Jennifer A. Phipps reported multiple equity transactions. She sold 35,000 shares of common stock at $41.15 per share in a registered public offering that closed on March 4, 2026, while exercising 35,000 stock options at $6.37 per share.
She also acquired several equity awards. On March 5, 2026, she received 53,384 restricted stock units that vest in three equal annual installments beginning on January 25, 2027. Performance-based stock options granted in 2019 and 2020 vested after performance conditions were satisfied, and additional options vest over three years starting January 25, 2027. Following these transactions, she directly owned 196,840 shares of common stock and 130,860 stock options.
BrightSpring Health Services major shareholder entities associated with KKR reported several transactions in the company’s common stock. An affiliated holder, KKR Phoenix Aggregator L.P., sold 19,715,000 shares in an underwritten public offering at a net price of $40.961 per share. After these transactions, affiliated entities reported holding 41,824,259 shares of common stock. Additional movements included in-kind distributions that allowed ultimate recipients to make charitable donations of shares, with Messrs. Henry R. Kravis and George R. Roberts each donating shares they received. The reporting persons collectively disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest.
KKR-affiliated entities reported several transactions in BrightSpring Health Services common stock. The main move was an open-market sale of 19,715,000 shares at a net price of $40.961 per share through an underwritten public offering, leaving tens of millions of shares still indirectly held.
Additional entries cover 402,773 shares reclassified in connection with this sale, plus two bona fide gifts of 49,295 and 31,918 shares. Footnotes explain that these shares were distributed in kind to partners and shareholders so that ultimate recipients, including Messrs. Henry R. Kravis and George R. Roberts, could donate shares to charity. The reporting entities collectively disclaim beneficial ownership beyond any pecuniary interest.